280 related articles for article (PubMed ID: 34018627)
1. Combination of Model for End-Stage Liver Disease and Lactate Predicts Death in Patients Treated With Salvage Transjugular Intrahepatic Portosystemic Shunt for Refractory Variceal Bleeding.
Walter A; Rudler M; Olivas P; Moga L; Trépo E; Robic MA; Ollivier-Hourmand I; Baiges A; Sutter O; Bouzbib C; Peron JM; Le Pennec V; Ganne-Carrié N; Garcia-Pagán JC; Mallet M; Larrue H; Dao T; Thabut D; Hernández-Gea V; Nault JC; Bureau C; Allaire M;
Hepatology; 2021 Oct; 74(4):2085-2101. PubMed ID: 34018627
[TBL] [Abstract][Full Text] [Related]
2. Predictors of Re-bleeding and Mortality Among Patients with Refractory Variceal Bleeding Undergoing Salvage Transjugular Intrahepatic Portosystemic Shunt (TIPS).
Maimone S; Saffioti F; Filomia R; Alibrandi A; Isgrò G; Calvaruso V; Xirouchakis E; Guerrini GP; Burroughs AK; Tsochatzis E; Patch D
Dig Dis Sci; 2019 May; 64(5):1335-1345. PubMed ID: 30560334
[TBL] [Abstract][Full Text] [Related]
3. Transjugular Intrahepatic Porto-Systemic Shunt in Patients with Liver Cirrhosis and Model for End-Stage Liver Disease ≥15.
Ascha M; Hanouneh M; S Ascha M; Zein NN; Sands M; Lopez R; Hanouneh IA
Dig Dis Sci; 2017 Feb; 62(2):534-542. PubMed ID: 27154510
[TBL] [Abstract][Full Text] [Related]
4. Decision making for transjugular intrahepatic portosystemic stent shunt in refractory ascites and variceal bleeding: MELD, or not MELD, that is the question.
Pitton MB; Zimmermann T; Mildenberger P; Weinmann A; Kloeckner R; Düber C; Mittler J; Hoppe-Lotichius M; Otto G
Eur J Gastroenterol Hepatol; 2021 Dec; 33(1S Suppl 1):e214-e222. PubMed ID: 33230020
[TBL] [Abstract][Full Text] [Related]
5. Long-term clinical outcome and survival predictors in patients with cirrhosis after 10-mm-covered transjugular intrahepatic portosystemic shunt.
Tejedor-Tejada J; Fuentes-Valenzuela E; García-Pajares F; Nájera-Muñoz R; Almohalla-Álvarez C; Sánchez-Martín F; Calero-Aguilar H; Villacastín-Ruiz E; Pintado-Garrido R; Sánchez-Antolín G
Gastroenterol Hepatol; 2021 Nov; 44(9):620-627. PubMed ID: 33249114
[TBL] [Abstract][Full Text] [Related]
6. Salvage transjugular intrahepatic portosystemic shunt in patients with cirrhosis and refractory variceal bleeding: A systematic review with meta-analysis.
Weichselbaum L; Lepida A; Marot A; Trépo E; Moreno C; Deltenre P
United European Gastroenterol J; 2022 Oct; 10(8):874-887. PubMed ID: 36217553
[TBL] [Abstract][Full Text] [Related]
7. Shunting branch of portal vein and stent position predict survival after transjugular intrahepatic portosystemic shunt.
Bai M; He CY; Qi XS; Yin ZX; Wang JH; Guo WG; Niu J; Xia JL; Zhang ZL; Larson AC; Wu KC; Fan DM; Han GH
World J Gastroenterol; 2014 Jan; 20(3):774-85. PubMed ID: 24574750
[TBL] [Abstract][Full Text] [Related]
8. Model for end-stage liver disease score and hemodynamic instability as a predictor of poor outcome in early transjugular intrahepatic portosystemic shunt treatment for acute variceal hemorrhage.
Hermie L; Dhondt E; Vanlangenhove P; Hoste E; Geerts A; Defreyne L
Eur J Gastroenterol Hepatol; 2018 Dec; 30(12):1441-1446. PubMed ID: 30048333
[TBL] [Abstract][Full Text] [Related]
9. Prediction of mortality after emergent transjugular intrahepatic portosystemic shunt placement: use of APACHE II, Child-Pugh and MELD scores in Asian patients with refractory variceal hemorrhage.
Tzeng WS; Wu RH; Lin CY; Chen JJ; Sheu MJ; Koay LB; Lee C
Korean J Radiol; 2009; 10(5):481-9. PubMed ID: 19721833
[TBL] [Abstract][Full Text] [Related]
10. Factors influencing in-hospital mortality for salvage percutaneous transjugular intrahepatic portosystemic shunting in cirrhotic patients with recalcitrant variceal bleeding after failed endoscopic intervention.
Krige JEJ; Jonas EG; Setshedi M; Beningfield SJ; Lotze UK; Bernon MM; Burmeister S; Kloppers JC
S Afr Med J; 2023 Dec; 114(1):39-43. PubMed ID: 38525611
[TBL] [Abstract][Full Text] [Related]
11. Right atrial pressure may impact early survival of patients undergoing transjugular intrahepatic portosystemic shunt creation.
Parvinian A; Bui JT; Knuttinen MG; Minocha J; Gaba RC
Ann Hepatol; 2014; 13(4):411-9. PubMed ID: 24927612
[TBL] [Abstract][Full Text] [Related]
12. Transjugular intrahepatic portosystemic shunts and portal hypertension-related complications.
Siramolpiwat S
World J Gastroenterol; 2014 Dec; 20(45):16996-7010. PubMed ID: 25493012
[TBL] [Abstract][Full Text] [Related]
13. The role of transjugular intrahepatic portosystemic shunt (TIPS) in the management of portal hypertension.
Colombato L
J Clin Gastroenterol; 2007; 41 Suppl 3():S344-51. PubMed ID: 17975487
[TBL] [Abstract][Full Text] [Related]
14. Refining prediction of survival after TIPS with the novel Freiburg index of post-TIPS survival.
Bettinger D; Sturm L; Pfaff L; Hahn F; Kloeckner R; Volkwein L; Praktiknjo M; Lv Y; Han G; Huber JP; Boettler T; Reincke M; Klinger C; Caca K; Heinzow H; Seifert LL; Weiss KH; Rupp C; Piecha F; Kluwe J; Zipprich A; Luxenburger H; Neumann-Haefelin C; Schmidt A; Jansen C; Meyer C; Uschner FE; Brol MJ; Trebicka J; Rössle M; Thimme R; Schultheiss M
J Hepatol; 2021 Jun; 74(6):1362-1372. PubMed ID: 33508376
[TBL] [Abstract][Full Text] [Related]
15. Long-term effects and complications of the transjugular intrahepatic portosystemic shunt: a single-centre experience.
Kraglund F; Jepsen P; Amanavicius N; Aagaard NK
Scand J Gastroenterol; 2019 Jul; 54(7):899-904. PubMed ID: 31203699
[No Abstract] [Full Text] [Related]
16. Clinical outcome and predictors of survival after TIPS insertion in patients with liver cirrhosis.
Heinzow HS; Lenz P; Köhler M; Reinecke F; Ullerich H; Domschke W; Domagk D; Meister T
World J Gastroenterol; 2012 Oct; 18(37):5211-8. PubMed ID: 23066315
[TBL] [Abstract][Full Text] [Related]
17. Characteristics and outcomes of transjugular intrahepatic portosystemic shunt recipients in the VA Healthcare System.
Lerrigo R; Beste LA; Leipertz SL; Green PK; Lok AS; Kogut MJ; Ioannou GN
Eur J Gastroenterol Hepatol; 2016 Jun; 28(6):667-75. PubMed ID: 26886386
[TBL] [Abstract][Full Text] [Related]
18. Applying the original model for end-stage liver disease score rather than the model for end-stage liver disease-Na score for risk stratification prior to transjugular intrahepatic portosystemic shunt procedures.
Lee BT; Yang AH; Urban S; Kim KY; Ter-Oganesyan R; Yuan L; Han HH; Khemichian S; Kahn JA; Kim B
Eur J Gastroenterol Hepatol; 2021 Apr; 33(4):541-546. PubMed ID: 32398491
[TBL] [Abstract][Full Text] [Related]
19. Rapid change of liver stiffness after variceal ligation and TIPS implantation.
Piecha F; Paech D; Sollors J; Seitz HK; Rössle M; Rausch V; Mueller S
Am J Physiol Gastrointest Liver Physiol; 2018 Feb; 314(2):G179-G187. PubMed ID: 29051188
[TBL] [Abstract][Full Text] [Related]
20. Emergent rescue transjugular intrahepatic portosystemic shunt within 8 h improves survival in patients with refractory variceal bleed.
Mukund A; Vasistha S; Jindal A; Patidar Y; Sarin SK
Hepatol Int; 2023 Aug; 17(4):954-966. PubMed ID: 36787012
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
